Diversified Healthcare Trust 5.625% Senior Notes due 2042
16.98
USD
Patrocinado
+0.34
+2.04%
09 de jan., 15:51 UTC -5
Encerrado
Pós-Mercado
16.98
0.00
0.00%
Relatórios de Lucros DHCNI
Rácio de surpresa positiva
DHCNI separação 13 de 40 últimas estimativas.
33%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate forQ4 25(Revenue/ EPS)
$396.82M
/
-$0.17
Mudanças implicadas deQ3 25(Revenue/ EPS)
+2.09%
/
-75.00%
Mudanças implicadas deQ4 24(Revenue/ EPS)
+4.53%
/
-52.78%
Diversified Healthcare Trust 5.625% Senior Notes due 2042 earnings per share and revenue
On 03 de nov. de 2025, DHCNI reported earnings of -0.68 USD per share (EPS) for Q3 25, missing the estimate of -0.21 USD, resulting in a -213.08% surprise. Revenue reached 388.71 milhão, compared to an expected 386.12 milhão, with a 0.67% difference. The market reacted with a +0.01% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.17 USD, with revenue projected to reach 396.82 milhão USD, implying an diminuir of -75.00% EPS, and aumentar of 2.09% in Revenue from the last quarter.
FAQ
What were Diversified Healthcare Trust 5.625% Senior Notes due 2042's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Diversified Healthcare Trust 5.625% Senior Notes due 2042 reported EPS of -$0.68, missing estimates by -213.08%, and revenue of $388.71M, 0.67% above expectations.
How did the market react to Diversified Healthcare Trust 5.625% Senior Notes due 2042's Q3 2025 earnings?
The stock price moved up 0.01%, changed from $17.05 before the earnings release to $17.05 the day after.
When is Diversified Healthcare Trust 5.625% Senior Notes due 2042 expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Diversified Healthcare Trust 5.625% Senior Notes due 2042's next earnings report?
Based on 3
analistas, Diversified Healthcare Trust 5.625% Senior Notes due 2042 is expected to report EPS of -$0.17 and revenue of $396.82M for Q4 2025.